SLN
Silence Therapeutics PLC
10.90$
+1.2%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -63,053.3% | – | -1,307.3% | -59,993.8% | – | 707.8% | -196.7% | 74.0% | -323.1% | -155.1% | -124.9% | -11,139.7% | |
| 2,213.3% | – | 40.3% | 2,706.3% | – | 197.5% | 9.1% | 4.6% | 3.4% | 2.0% | 1.1% | 99.3% | |
| 7,513.3% | – | 61.7% | 3,987.5% | – | 239.3% | 80.2% | 93.8% | 71.9% | 51.4% | 24.1% | 1,444.4% | |
| – | – | -181.4% | -63,281.3% | – | -105.7% | 136.6% | 55.9% | 15.9% | – | – | – | |
| -100.0% | – | -133.8% | 4,150.0% | – | 8,641.4% | 340.5% | 422.3% | -109.9% | -46.0% | -61.0% | 1,817.4% | |
| 2,253.3% | – | 69.7% | 1,081.3% | – | 3.7% | 9.4% | 14.5% | 3.1% | 0.2% | 0.4% | 9.8% | |
| -1,340.0% | – | -607.1% | 81,337.5% | – | -6,153.7% | 175.5% | 94.3% | -116.1% | 64.7% | -40.6% | -8,585.3% | |
| – | – | -13.1% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | -2,512.5% | – | -164.8% | -7.3% | -1.7% | -1.1% | -0.9% | – | – | |
| 72,293.3% | – | -13.1% | 300.0% | – | 2,161.1% | 281.6% | 333.9% | 297.9% | 99.1% | 262.5% | 2.7% | |
| 6,446.7% | – | -1,674.7% | 23,331.3% | – | -3,270.1% | 254.3% | 501.0% | -187.4% | -3.1% | 97.1% | -19,687.5% | |
| -65,306.7% | – | -1,377.0% | -61,075.0% | – | 704.1% | -206.1% | 59.5% | -326.2% | -155.3% | -125.3% | -11,149.6% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.